经皮与开放植入脊髓电刺激的并发症系统综述与荟萃分析
该研究系统检索了PubMed和Embase自建库至2020年6月的文献,纳入报告并发症及植入方式的脊髓电刺激前瞻性研究,患者涵盖背部手术失败综合征、复杂性区域疼痛综合征及慢性腰腿痛。荟萃分析显示总体平均并发症率为21.1%(95%CI,14.9-27.2),器械相关并发症占多数;与开放植入相比,经皮植入的因医疗相关并发症再干预和因感染取出更少。
要点
- 脊髓电刺激总体平均并发症率为21.1%(95%CI,14.9-27.2)。
- 器械相关并发症最常见,发生率为12.1%。
- 经皮植入因医疗相关并发症再干预和因感染取出均少于开放植入。
核心结论
- 脊髓电刺激并发症以器械相关为主,总体平均并发症率为21.1%(95%CI,14.9-27.2)。
- 经皮脊髓电刺激因医疗相关并发症再干预及因感染取出均少于开放植入。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed和Embase自建库至2020年6月。
- 纳入报告并发症及植入方式的前瞻性脊髓电刺激研究,覆盖背部手术失败综合征、复杂性区域疼痛综合征和慢性腰背痛。
主要发现
- 总体平均并发症率为21.1%(95%CI,14.9-27.2)。
- 器械、技术和医疗并发症发生率分别为12.1%、1.1%和6.3%。
- 电极移位和感染率分别为5.6%和3.8%。
- 因医疗相关并发症的再干预及因感染的取出在开放植入中比经皮植入更常见。
临床怎么用
- 选择脊髓电刺激植入方式时可参考本荟萃分析:经皮植入在医疗相关再干预和感染取出方面少于开放植入。
- 术前咨询可告知患者总体平均并发症率约21.1%,其中器械相关并发症占多数。
局限性
- 仅纳入报告并发症及植入方式的前瞻性研究,检索截止2020年6月,未涵盖此后证据。
- 原文摘要未报告纳入研究的样本量、偏倚风险及异质性指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Spinal cord stimulation (SCS) has become a successful therapeutic option for combating chronic pain and can be implanted via percutaneous or open (laminotomy/laminectomy) techniques. This study aimed to systematically review the complications that occur after SCS placement via percutaneous and open (laminotomy/laminectomy) in failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), and chronic back (lumbosacral)/leg pain. METHODS: The PubMed and Embase databases were searched from inception to June 2020; prospective studies using SCS in patients with FBSS, CRPS, and chronic low back pain that reported both complications and the implantation method used were included. Effects and results from each study were combined using a random-effects model and were structured for subgroup analysis between open implantation and percutaneous implantation. Meta-regression was performed by calculating a mean difference and weighted by inverse variance and 95% confidence intervals (CIs). RESULTS: Thirty-two articles were included in this systematic review and meta-analysis. Using several different patient- and event-based metrics, our meta-analysis revealed an overall average complication rate of 21.1% (95% CI, 14.9-27.2). Equipment, technical, and medical complications occurred at rates of 12.1%, 1.1%, and 6.3%, respectively. Lead migration and infection rates were 5.6% and 3.8%, respectively. When comparing the 2 implant techniques, medical-related surgical reinterventions and explants due to infection were more common in open compared with percutaneous SCS procedures. CONCLUSIONS: Equipment-related complications accounted for the majority of SCS complications. Percutaneous SCS resulted in less reintervention and fewer explants caused by medical-related complications and infection, respectively. These conclusions may provide a general understanding of the SCS complications profile for physicians who care for SCS patients.
引用
- Blackburn AZ, Chang HH, DiSilvestro K, et al. Spinal Cord Stimulation via Percutaneous and Open Implantation: Systematic Review and Meta-Analysis Examining Complication Rates. World Neurosurg. 2021. PMID: 34343680. doi:10.1016/j.wneu.2021.07.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。